207 related articles for article (PubMed ID: 25033163)
21. The progress of cognitive decline in newly diagnosed MS patients.
Hankomäki E; Multanen J; Kinnunen E; Hämäläinen P
Acta Neurol Scand; 2014 Mar; 129(3):184-91. PubMed ID: 23773012
[TBL] [Abstract][Full Text] [Related]
22. Information-processing speed is the primary deficit underlying the poor performance of multiple sclerosis patients in the Paced Auditory Serial Addition Test (PASAT).
Forn C; Belenguer A; Parcet-Ibars MA; Avila C
J Clin Exp Neuropsychol; 2008 Oct; 30(7):789-96. PubMed ID: 18608672
[TBL] [Abstract][Full Text] [Related]
23. Visual-cognitive processing deficits in pediatric multiple sclerosis.
Smerbeck AM; Parrish J; Serafin D; Yeh EA; Weinstock-Guttman B; Hoogs M; Krupp LB; Benedict RH
Mult Scler; 2011 Apr; 17(4):449-56. PubMed ID: 21343232
[TBL] [Abstract][Full Text] [Related]
24. The computer-based Symbol Digit Modalities Test: establishing age-expected performance in healthy controls and evaluation of pediatric MS patients.
Bigi S; Marrie RA; Till C; Yeh EA; Akbar N; Feinstein A; Banwell BL
Neurol Sci; 2017 Apr; 38(4):635-642. PubMed ID: 28078569
[TBL] [Abstract][Full Text] [Related]
25. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N
Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348
[TBL] [Abstract][Full Text] [Related]
26. Incidental learning during rapid information processing on the symbol-digit modalities test.
Denney DR; Hughes AJ; Elliott JK; Roth AK; Lynch SG
Arch Clin Neuropsychol; 2015 Jun; 30(4):322-8. PubMed ID: 25857404
[TBL] [Abstract][Full Text] [Related]
27. Cognitive impairment in multiple sclerosis.
Jongen PJ; Ter Horst AT; Brands AM
Minerva Med; 2012 Apr; 103(2):73-96. PubMed ID: 22513513
[TBL] [Abstract][Full Text] [Related]
28. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
[TBL] [Abstract][Full Text] [Related]
29. Unemployment in multiple sclerosis (MS): utility of the MS Functional Composite and cognitive testing.
Strober L; Chiaravalloti N; Moore N; DeLuca J
Mult Scler; 2014 Jan; 20(1):112-5. PubMed ID: 23635909
[TBL] [Abstract][Full Text] [Related]
30. Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
Drake AS; Weinstock-Guttman B; Morrow SA; Hojnacki D; Munschauer FE; Benedict RH
Mult Scler; 2010 Feb; 16(2):228-37. PubMed ID: 20028710
[TBL] [Abstract][Full Text] [Related]
31. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
32. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Papadopoulou A; Müller-Lenke N; Naegelin Y; Kalt G; Bendfeldt K; Kuster P; Stoecklin M; Gass A; Sprenger T; Radue EW; Kappos L; Penner IK
Mult Scler; 2013 Sep; 19(10):1290-6. PubMed ID: 23459568
[TBL] [Abstract][Full Text] [Related]
33. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
[TBL] [Abstract][Full Text] [Related]
34. Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.
Benedict RH; Duquin JA; Jurgensen S; Rudick RA; Feitcher J; Munschauer FE; Panzara MA; Weinstock-Guttman B
Mult Scler; 2008 Aug; 14(7):940-6. PubMed ID: 18573822
[TBL] [Abstract][Full Text] [Related]
35. Selective decline in information processing in subgroups of multiple sclerosis: an 8-year longitudinal study.
Bergendal G; Fredrikson S; Almkvist O
Eur Neurol; 2007; 57(4):193-202. PubMed ID: 17272938
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-up.
Amato MP; Goretti B; Ghezzi A; Hakiki B; Niccolai C; Lori S; Moiola L; Falautano M; Viterbo RG; Patti F; Cilia S; Pozzilli C; Bianchi V; Roscio M; Martinelli V; Comi G; Portaccio E; Trojano M;
Neurology; 2014 Oct; 83(16):1432-8. PubMed ID: 25217060
[TBL] [Abstract][Full Text] [Related]
37. Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.
Benedict RH; Smerbeck A; Parikh R; Rodgers J; Cadavid D; Erlanger D
Mult Scler; 2012 Sep; 18(9):1320-5. PubMed ID: 22277740
[TBL] [Abstract][Full Text] [Related]
38. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis.
Sumowski JF; Chiaravalloti N; Wylie G; Deluca J
J Int Neuropsychol Soc; 2009 Jul; 15(4):606-12. PubMed ID: 19573279
[TBL] [Abstract][Full Text] [Related]
39. Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Sumowski JF; Rocca MA; Leavitt VM; Dackovic J; Mesaros S; Drulovic J; DeLuca J; Filippi M
Neurology; 2014 May; 82(20):1776-83. PubMed ID: 24748670
[TBL] [Abstract][Full Text] [Related]
40. Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline.
Morrow SA; Drake A; Zivadinov R; Munschauer F; Weinstock-Guttman B; Benedict RH
Clin Neuropsychol; 2010 Oct; 24(7):1131-45. PubMed ID: 20830649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
